Abstract
Historically, randomized trials and meta-analyses have demonstrated a benefit in local control, and breast cancer mortality with adjuvant whole breast irradiation (WBI) following breast-conserving surgery (BCS). However, review of patterns of failure in patients undergoing breast-conserving therapy has demonstrated that the majority of local recurrences occur within close proximity to the lumpectomy cavity. Accelerated partial breast irradiation (APBI), which is based on the concept of radiotherapy to the area surrounding the lumpectomy cavity, has emerged as a treatment option for women with early-stage breast cancer over the past several decades. By limiting the volume of normal tissue treated, APBI has the potential for reduced toxicity, but also improved patient convenience as treatment is completed in 1 week or less. This directly addresses the underutilization of breast-conserving therapy and offers a solution to the large number of patients who fail to complete the 5–6-week course of adjuvant external beam WBI due to social and economic considerations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.
Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–9.
Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.
Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.
Wilkinson JB, Martinez AA, Chen PY, et al. Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule. Brachytherapy. 2012;11:97–104.
Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep. 2008;10:54–60.
White A, Richardson LC, Krontiras H, et al. Socioeconomic disparities in breast cancer treatment among older women. J Women Health. 2014;23:335–41.
Brown S, McLaughlin M, Pope DK, et al. A dosimetric comparison of the multilumen balloon breast brachytherapy catheter vs. the single-lumen MammoSite balloon device in patients treated with accelerated partial breast irradiation at a single institution. Brachytherapy. 2011;10:68–73.
Gurdalli S, Kuske RR, Quiet CA, et al. Dosimetric performance of Strut-Adjusted Volume Implant: a new single-entry multicatheter breast brachytherapy applicator. Brachytherapy. 2011;10:128–35.
Poti Z, Nemeskeri C, Fekeshazy A, et al. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow up of 70 patients. Int J Radiat Oncol Biol Phys. 2004;5:1022–33.
Fentiman IS, Deshmane V, Tong D, et al. Caesium (137) implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol. 2004;71:281–5.
Cionini L, Marzano S, Pacini P, et al. Iridium implant of the surgical bed as the sole radiotherapeutic treatment after conservative surgery for breast cancer. Radiother Oncol. 1995;35:S1.
Polgar C, Major T, Fodor J, et al. Accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol. 2010;94:274–9.
Polgar C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108:197–202.
Arthur DW, Winter K, Kuske RR, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2008;72:467–73.
Rabinovitch R, Winter K, Kuske R, et al. RTOG 95–17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma- year 5 toxicity and cosmesis. Brachytherapy. 2014;13:17–22.
Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol. 2011;100:210–4.
Ferraro DJ, Garsa AA, Dewees TA, et al. Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation. Radiat Oncol. 2012;7:53.
Garsa AA, Ferraro DJ, Dewees T, et al. Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer. Brachytherapy. 2013;12:99–106.
Garsa AA, Ferraro DJ, DeWees T, et al. Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys. 2013;85(4):965–70.
Hattangadi JA, Powell SN, MacDonald SM, et al. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012;83:791–800.
Strnad V, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2011;80:17–24.
Ott OJ, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects, and cosmetic outcomes for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol. 2007;82:281–6.
King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299–304.
Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with Stage I breast cancer. Breast J. 2001;7:91–6.
Patel RR, Christensen ME, Hodge CW, et al. Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413: five-year results. Int J Radiat Oncol Biol Phys. 2008;70:970–3.
Arthur D, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–9.
Johansson B, Karlsson L, Liljegren G, et al. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-2 breast cancer: first long time results from a clinical study. Radiother Oncol. 2009;90:30–5.
Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–62.
Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32–40.
Shah C, Badiyan S, Ben Wilkinson J, et al. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Ann Surg Oncol. 2013;20:3279–85.
Shah C, Khwaja S, Badiyan S, et al. Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy. 2013;12:278–84.
Cuttino LW, Keisch M, Jenrette JM, et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys. 2008;71:107–14.
Chen S, Dickler A, Kirk M, et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys. 2007;69:25–31.
Harper JL, Watkins JM, Zauls AJ, et al. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010;199:204–9.
Haley M, Beriwal S, Heron DE, et al. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup. Brachytherapy. 2009;8:9–13.
Shah NM, Tenenholz T, Arthur D. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer. 2004;101:727–34.
Evans SB, Kaufman SA, Price LL, et al. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys. 2006;65:333–9.
Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11:739–46.
Niehoff P, Polgar C, Ostertag H, et al. Clinical experience with MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79:316–20.
Shah C, Ghilezan M, Arthur D, et al. Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation. Brachytherapy. 2012;11:369–73.
Cuttino LW, Arthur DW, Vicini F, et al. Long-term results from the Contura Multi-Lumen balloon breast brachytherapy catheter phase 4 registry trial. Int J Radiat Oncol Biol Phys. 2014;90:1025–9.
Israel PZ, Robbins A, Shroff P, et al. Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): improving radiation standards for the optimal application of APBI. Brachytherapy. 2012;11:316–21.
Yashar CM, Blair S, Wallace A, et al. Initial clinical experience with strut-adjusted volume implant brachytherapy applicator for accelerated partial breast irradiation. Brachytherapy. 2009;8:367–72.
Yashar CM, Scanderberg D, Kuske R, et al. Initial clinical experience with the strut-adjusted volume implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year follow-up. Int J Radiat Oncol Biol Phys. 2011;80:765–70.
Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307:1827–37.
Presley CJ, Soulos PR, Herrin J, et al. Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008–2009. J Clin Oncol. 2012;30:4302–7.
Chen PY. Accelerated partial breast irradiation: keeping guidelines in step with evolving data. Int J Radiat Oncol Biol Phys. 2014;88:263–5.
Kuske RR, Young SS. Breast brachytherapy versus whole-breast irradiation: reported differences may be statistically significant but clinically trivial. Int J Radiat Oncol Biol Phys. 2014;88:266–8.
Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomized trial. Radiother Oncol. 1996;39:223–7.
Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancers. Clin Oncol. 2005;17:618–22.
Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55:302–11.
Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60:493–504.
Olivotto IA, Whelan TJ, Parpia S, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31:4038–35.
Chafe S, Moughan J, McCormick B, et al. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer. Int J Radiat Oncol Biol Phys. 2013;86:854–9.
Liss AL, Ben-David MA, Jagsi R, et al. Decline of cosmetic outcomes follow accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial. Int J Radiat Oncol Biol Phys. 2014;89:96–102.
Leonard KL, Hepel JT, Hiatt JR, et al. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013;85:623–9.
Shah C, Wilkinson JB, Lanni T, et al. Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Clin Breast Cancer. 2013;13:206–11.
Formenti SC, Hsu H, Fenton-Kerimian M, et al. Prone accelerated partial irradiation after breast-conserving surgery: five-year results of 100 patients. Int J Radiat Oncol Biol Phys. 2012;84:606–11.
Julian TB, Constantino JP, Vicini FA, et al. Early toxicity results with 3D conformal external beam (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. Presented at the 2011 American Society of Clinical Oncology annual meeting, 4–8 June 2011, Chicago.
Lei RY, Leonard CE, Howell KT, et al. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat. 2013;140:119–33.
Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.
Taghian AG, Kozak KR, Katz A, et al. Accelerated partial breast irradiation using proton beams: initial dosimetric experience. Int J Radiat Oncol Biol Phys. 2006;65:1404–10.
Kozak RR, Smith BL, Adams J, et al. Accelerated partial- breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys. 2006;66:691–8.
Galland-Girodet S, Pashtan I, MacDonald SM, et al. Long-term cosmetic outcomes and toxicities of proton therapy compared with photon-based-3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial. Int J Radiat Oncol Biol Phys. 2014;90:493–500.
Bush DA, Do S, Lum S, et al. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes. Int J Radiat Oncol Biol Phys. 2014;90:501–5.
Berrang TS, Olivotto I, Kim DH, et al. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Int Radiat Oncol Biol Phys. 2011;81:1220–7.
Chang JH, Lee NK, Kim JY, et al. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer. Radiother Oncol. 2013;108:209–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Shah, C., Parsai, S., Kotecha, R., Tendulkar, R., Vicini, F.A. (2016). Overview of Outcomes with Accelerated Partial Breast Irradiation. In: Arthur, D., Vicini, F., Wazer, D., Khan, A. (eds) Short Course Breast Radiotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-24388-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-24388-7_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24386-3
Online ISBN: 978-3-319-24388-7
eBook Packages: MedicineMedicine (R0)